- Type / Class
- Equity / COM
- Total 13F shares
- 104,487
- Share change
- +82,621
- Total reported value
- $122,250
- Price per share
- $1.17
- Number of holders
- 5
- Value change
- +$79,322
- Number of buys
- 5
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP 016744500?
CUSIP 016744500 identifies ALLR - Allarity Therapeutics, Inc. - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 016744500:
Top shareholders of ALLR - Allarity Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
18,452
|
$38,934 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
3,403
|
$7,180 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
11
|
$23 | — | 30 Sep 2024 | |
| DANSKE BANK A/S |
13F
|
Company |
—
class O/S missing
|
8
|
$17 | — | 30 Sep 2024 | |
| Leon Sass* |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,086,238
|
— | — | 20 Dec 2021 | |
| Steen Knudsen |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
124,976
|
— | — | 20 Dec 2021 | |
| Duncan Moore |
3/4/5
|
Director |
—
class O/S missing
|
22,672
|
— | — | 20 Dec 2021 | |
| Marie Foegh |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
3,988
|
— | — | 20 Dec 2021 | |
| Soren Gade Jensen |
3/4/5
|
Director |
—
class O/S missing
|
2,800
|
— | — | 20 Dec 2021 |
Institutional Holders of Allarity Therapeutics, Inc. - COM (ALLR) as of Q4 2024
As of 31 Dec 2024,
Allarity Therapeutics, Inc. - COM (ALLR) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
104,487 shares.
The largest 6 holders included
Stonepine Capital Management, LLC, GOLDMAN SACHS GROUP INC, CITIGROUP INC, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, and DANSKE BANK A/S.
This page lists
6
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
3
Q4 2024 holders
5
Holder diff
2
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.